HOME
>
臨床医学：内科
>
脳神経科学/神経内科学
> 神経内科外来シリーズ　1　頭痛外来

神経内科外来シリーズ　1　頭痛外来

出版社：	メジカルビュー社
著者：	荒木信夫(総編集) 荒木信夫(担当編集)
発行日：	2015-03-20
分野：	臨床医学：内科 > 脳神経科学/神経内科学
ISBN：	9784758303828
シリーズ：	神経内科外来シリーズ
電子書籍版：	2015-03-20 （第1版第1刷）

書籍・雑誌

≪全国送料無料でお届け≫

取寄せ目安：8～14営業日

7,700 円(税込)

購入する

電子書籍

章別単位での購入はできません

ブラウザ、アプリ閲覧

7,700 円(税込)

購入する

商品紹介

本巻では、現代人を悩ます頭痛を取り上げる。頭痛の基本的知識、外来の基本的な流れを解説した後、頭痛のなかでも特に外来でみる機会の多い片頭痛、緊張型頭痛、群発頭痛、薬物乱用頭痛、小児・思春期の頭痛、およびその他の一時頭痛を取り上げ、各々の治療を解説する。またそれぞれCase Studyを呈示し、診療の実際に触れられるようにした。

目次

神経内科外来シリーズ　1　頭痛外来

―目次―

?　頭痛についての基礎知識
　頭痛とは？―頭痛のメカニズム―
　頭痛分類
　頭痛の疫学・遺伝

II　外来の基本的な流れ
　診察・診断の基本
　鑑別疾患
　●基本的な治療の進め方：薬物療法
　　識っておくべき薬物の知識、最新の薬剤について　
　　漢方薬　
　●基本的な治療の進め方：非薬物療法
　　認知行動療法　
　　理学療法、作業療法、心理カウンセリングなど　
　　痛ダイアリー　
　　頭痛診療におけるチーム医療と頭痛教室　

III　各頭痛の診断と治療の進め方
　片頭痛
　緊張型頭痛
　群発頭痛
　薬剤の使用過多による頭痛(薬物乱用頭痛)
　小児・思春期の頭痛
　その他の一次性頭痛　

付録
　本書掲載の治療薬一覧（片頭痛、緊張型頭痛、群発頭痛）
　頭痛外来への紹介状

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 頭痛についての基礎知識

P.12 掲載の参考文献

1) Olesen J, et al. Origin of pain in migraine : evidence for peripheral sensitisation. Lancet Neurol 2009 ; 8 : 679-90.

2) Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984 ; 16 : 157-68.

3) Noseda R, et al. Migraine pathophysiology : anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 2013 ; 154 : S44-53.

4) Hadjikhani N, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. PNAS 2001 ; 98 : 4687-92.

5) Blau JN. Migraine : theories of pathogenesis. Lancet 1992 ; 339 : 1202-7.

6) 柴田護. 片頭痛のメカニズムと診断の実際. Mebio 2014 ; 31 (6) : 8-16.

7) 柴田護. 緊張型頭痛に対応する. 鈴木則宏, 清水利彦, 柴田護. これでわかる頭痛診療, 南江堂, 東京, 2010, p59-74.

8) Leone M, et al. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol 2009 ; 8 : 755-64.

P.22 掲載の参考文献

1) Headache Classification Committee of the International Headache S. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (Suppl 7) : 1-96, 1988.

2) Headache Classification Subcommittee of the International Headache S. The International Classification Of Headache Disorders ; 2nd Edition. Cephalalgia 24 (suppl 1) : 1-160, 2004.

3) Society HCCotIH. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.

4) 日本頭痛学会・国際頭痛分類普及委員会訳. 国際頭痛分類第2版新訂増補日本語版, 医学書院, 東京, 2007.

5) 日本頭痛学会・国際頭痛分類委員会訳. 国際頭痛分類第3版 beta版, 医学書院, 東京, 2014.

P.31 掲載の参考文献

1) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988 ; 8 : 1-96.

2) Scher AI, Stewart WF, Lipton RB. Migraine and headache : a meta-analytic approach. In ; Crombie IK, ed. Epidemiology of Pain. Seattle : IASP Press 1999 : 159-70.

3) Sakai F, Igarashi H. Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 1997 ; 17 : 15-22.

4) Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan : the Daisen study. Headache 2004 ; 44 : 8-19.

5) Ando N, Fujimoto S, Ishikawa T, et al. Prevalence and features of migraine in Japanese junior high school students aged 12-15 yr. Brain Dev 2007 ; 29 : 482-5.

6) 桑原健太郎 : 小児の頭痛の疫学. 脳と発達 2012 ; 44 : 115-8.

7) 慢性頭痛の診療ガイドライン作成委員会編. 群発頭痛およびその他の三叉神経・自律神経性頭痛にはどの程度の患者が存在するのか. 危険因子, 増悪因子にはどのようなものが存在し, 患者の予後はどうか. 日本神経学会・日本頭痛学会監修, 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013, p221-2.

8) Tatsuoka Y : Headache in a Japanese secondary caresetting : Comparison with diagnosis prior to attendanceand analysis of referral pathway. Headache Care 2005 ; 2 : 145-9.

9) 永関慶重 : 片頭痛を見逃さないための頭痛診療のコツ-頭痛患者16,000例の治療経験から-. 慢性疼痛 2010 ; 29 : 31-7.

10) 慢性頭痛の診療ガイドライン作成委員会編. 遺伝子. 日本神経学会・日本頭痛学会監修, 慢性頭痛の診療ガイドライン 2013. 東京 : 医学書院 2013 : 291-303.

11) 古和久典, 中島健二 : 頭痛に関与している遺伝子-ゲノム解析の現状. 医学のあゆみ 2012 ; 243 : 1044-50.

12) Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013 ; 33 : 629-808.

13) 日本頭痛学会・国際頭痛分類委員会訳. 国際頭痛分類第3版 beta版, 医学書院, 東京, 2014.

14) 古和久典, 高橋祐二. 片頭痛の遺伝子診断はできるのか. Modern Physician 2013 ; 33 : 1205-9.

15) de Vries B, Frants RR, Ferrari MD, et al. Molecular genetics of migraine. Hum Genet 2009 ; 126 : 115-32.

II 外来の基本的な流れ

P.44 掲載の参考文献

1) 日本頭痛学会編. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013.

2) 濱田潤一. 内科コモンプロブレム頭痛. Medicina 2004 ; 41 : 592-6.

3) 濱田潤一. 頭痛. Medicina 2012 ; 49 : 575-9.

4) 日本頭痛学会・国際頭痛分類委員会訳 : 国際頭痛分類第3版 beta版. 医学書院, 東京, 2014.

5) Evans RW : Diagnostic testing for migraine and other primary headaches. Neurol Clin 27 : 393-415, 2009.

6) Lipton RB, Bigal ME ed. Migraine and other headache disorders. Informa Health Care, New York, 2006.

7) 濱田潤一. 頭痛診療と診療アルゴリズム. In ; 頭痛診療ハンドブック (鈴木則宏編集), 中外医学社, 東京, 2009, p23-30.

P.53 掲載の参考文献

1) 慢性頭痛の診療ガイドライン作成委員会. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013, p6-8.

2) van Gijn J, Rinkel GJ. Subarachnoid haemorrhage : diagnosis, causes and management. Brain 2001 ; 124 : 249-78.

3) van Gijn J, Kerr RS, et al. Subarachnoid haemorrhage. Lancet 2007 ; 369 (9558) : 306-18.

4) Lipton RB, Silberstein SD, et al : Why headache treatment fails. Neurology 2003 ; 60 : 1064-70.

5) Headache Classification Subcommittee of the International Headache Society : The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004 ; 24 : 9-160.

6) 日本頭痛学会・国際頭痛分類普及委員会訳. 国際頭痛分類第2版新訂増補日本語版, 医学書院, 東京, 2007.

7) Headache Classification Subcommittee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd Edition (beta version). Cephalalgia 2013 ; 33 : 629-808.

8) 日本頭痛学会・国際頭痛分類委員会訳. 国際頭痛分類第3版 beta版日本語版, 医学書院, 東京, 2014.

9) Detsky ME, McDonald DR, et al. Does this patient with headache have a migraine or need neuroimaging? JAMA 2006 ; 296 : 1274-83.

P.67 掲載の参考文献

1) Lipton RB, Stewart WF, et al. Disability in Strategies of Care Study group. Stratified care vs step care strategies for migraine : the Disability in Strategies of Care (DISC) Study : A randomized trial. JAMA 2000 ; 284 (20) : 2599-605.

2) Moschiano F, D'Amico D, et al. Early triptan intervention in migraine : an overview.Neurol Sci 2005 ; 26 Suppl 2 : s108-10.

3) D'Amico D, Moschiano F, et al. Early treatment of migraine attacks with triptans : a strategy to enhance outcomes and patient satisfaction? Expert Rev Neurother 2006 ; 6 (7) : 1087-97.

4) Goadsby PJ. The 'Act when Mild' (AwM) study : a step forward in our understanding of early treatment in acute migraine.Cephalalgia 2008 ; 28 Suppl 2 : 36-41.

5) Aurora SK, Barrodale PM, et al. Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine. Headache 2009 ; 49 (7) : 1001-4.

6) Lampl C, Huber G, et al. Difference in triptan effect in patients with migraine and early allodynia.Cephalalgia 2008 ; 28 (10) : 1031-8.

7) Markus F, Mikko K. Frovatriptan review. Expert Opin Pharmacother 2007 ; 8 : 3029-33

8) Allais G, Tullo V, et al. Efficacy of frovatritpan versus other triptans in the acute treatment of menstrual migraine : a pooled analysis of three double-blind, randomized, crossover, multicenter studies. Neurol Sci 2012 ; 33 (Suppl) : S65-9

9) Roberto G, Raschi E, et al. Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine : Systematic review of observational studies. Cephalalgia 2014 pii : 0333102414550416.

10) Sances G, Granella F, et al. Course of migraine during pregnancy and postpartum : a prospective study. Cephalalgia 2003 ; 23 (3) : 197-205.

11) Russell MB, Rasmussen BK, et al. Migraine without aura and migraine with aura are distinct clinical entities : a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996 ; 16 (4) : 239-45.

12) 日本神経学会・日本頭痛学会慢性頭痛の診療ガイドライン作成委員会. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013, pp139-41.

13) Briggs GG, Freeman RK, et al. Drugs in Pregnancy and Lactation : A Reference Guide to Fetal and Neonatal Risk. 9th edition, Lippincott Williams and Wilkins, Philadelphia, 2011.

14) Nezvalova-Henriksen K, Spigset O, et al. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes : results from the Norwegian Mother and Child Cohort Study. Headache 2010 ; 50 (4) : 563-75.

15) American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001 ; 108 (3) : 776-89.

16) Matok, Gorodischer R, et al. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 2009 ; 360 (24) : 2528-35.

17) Meador KJ, Baker GA, et al. NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study) : a prospective observational study. Lancet Neurol 2013 ; 12 (3) : 244-52.

18) Christensen J, Gr0nborg TK, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013 ; 309 (16) : 1696-703.

19) ACOG practice bulletin. Diagnosis and management of preeclampsia and ec- lampsia. Int J Gynaecol Obstet 2002 ; 77 : 67-75.

20) Pryse-Phillips WE, Dodick DW, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ 1997 ; 156 (9) : 1273-87.

21) Brandes JL, Saper JR, et al. MIGR-002 Study Group. Topiramate for migraine prevention : a randomized controlled trial. JAMA 2004 ; 291 (8) : 965-73.

22) Goldberg MR, Sciberras D, et al. Influence of betaadrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist : differential effects of propranolol, nadolol and metoprolol. Br J Clin Pharmacol 2001 ; 52 (1) : 69-76.

23) Tomkins GE, Jackson JL, et al. Treatment of chronic headache with antidepressants : a meta-analysis. Am J Med 2001 ; 111 (1) : 54-63.

24) 後藤文男, 田代邦雄, ほか. KB-2796 (塩酸ロメリジン) の片頭痛に対する臨床評価後期第II相臨床試験. 臨床評価 1995 ; 23 (1) : 13-37.

25) Solomon GD, Steel JG, et al. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. JAMA 1983 ; 250 (18) : 2500-2.

26) Markley HG, Cheronis JC, et al. Verapamil in prophylactic therapy of migraine. Neurology 1984 ; 34 (7) : 973-6.

27) Tronvik E, Stovner LJ, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol 2008 ; 8 : 4.

28) Tronvik E, Stovner LJ, et al. Prophylactic treatment of migraine with an angiotensin II receptor blocker : a randomized controlled trial. JAMA 2003 ; 289 (1) : 65-9.

29) Bendtsen L, Jensen R. Treating tension-type headache-an expert opinion. Expert Opin Pharmacother 2011 ; 12 (7) : 1099-109.

30) Hirata K, Tatsumoto M, et al. Multi-center randomized control trial of etizolam plus NSAID combination for tension-type headache. Intern Med 2007 ; 46 (8) : 467-72.

31) Gobel H, Lindner V, et al. Acute therapy for cluster headache with sumatriptan : findings of a one-year long-term study. Neurology 1998 ; 51 (3) : 908-11.

32) Treatment of acute cluster headache with sumatriptan. The Sumatriptan Cluster Headache Study Group. N Engl J Med 1991 ; 325 (5) : 322-6.

33) Cohen AS, Burns B, et al. High-flow oxygen for treatment of cluster headache : a randomized trial. JAMA 2009 ; 302 (22) : 2451-7.

34) Matharu MS, Levy MJ, et al. Subcutaneous octreotide in cluster headache : randomized placebo-controlled double-blind crossover study. Ann Neurol 2004 ; 56 (4) : 488-94.

35) Mir P, Alberca R, et al. Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone. Neurol Sci 2003 ; 24 (5) : 318-21.

36) Neeb L, Anders L, et al. Corticosteroids alter CGRP and melatonin release in cluster headache episodes.Cephalalgia 2014 epub ahead of print.

37) Saper JR, Klapper J, et al. Intranasal civamide for the treatment of episodic cluster headaches.Arch Neurol 2002 ; 59 (6) : 990-4.

38) Zebenholzer K, Wober C, et al. Eletriptan for the short-term prophylaxis of cluster headache. Headache 2004 ; 44 (4) : 361-4.

39) Stochino ME, Deidda A, et al. Evaluation of lithium response in episodic cluster headache : a retrospective case series. Headache 2012 ; 52 (7) : 1171-5.

40) Sjaastad O, Vincent M.Indomethacin responsive headache syndromes : chronic paroxysmal hemicrania and Hemicrania continua. How they were discovered and what we have learned since. Funct Neurol 2010 ; 25 (1) : 49-55.

41) Sjaastad O. Chronic paroxysmal hemicrania : from the index patient to the disease.Curr Pain Headache Rep. 2006 Aug ; 10 (4) : 295-301. Review.

42) 石崎公郁子, 竹島多賀夫, 井尻珠美, ほか. Hemicrania continuaの1例. 臨床神経 2002 ; 42 (8) : 754-6.

43) Sjaastad O. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT : the fate of the three first described cases. J Headache Pain 2006 ; 7 (3) : 151-6.

44) VanderPluym J. Indomethacin-responsive headaches. Curr Neurol Neurosci Rep 2015 ; 15 (2) : 516.

45) Lambru G, Matharu MS. SUNCT and SUNA : medical and surgical treatments. Neurol Sci 2013 ; 34 Suppl 1 : S75-81.

46) 福原葉子, 竹島多賀夫, 石崎公郁子, ほか. 睡眠時頭痛 (hypnic headache) の本邦III症例. 臨床神経学 2006 ; 46 (2) : 148-53

47) Dodick DW.Polysomnography in hypnic headache syndrome.Headache. 2000 ; 40 (9) : 748-52.

48) Chen SP, Fuh JL, et al. Recurrent primary thunderclap headache and benign CNS angiopathy : spectra of the same disorder? Neurology. 2006 ; 67 (12) : 2164-9.

P.75 掲載の参考文献

1) Odaguchi H, Wakasugi A, et al. The efficacy of goshuyuto, a typical Kampo (Japanese herbal medicine) formula, in preventing episodes of headache. Curr Med Res Opin 2006 ; 22 : 1587-97.

2) 丸山哲弘. 片頭痛予防における呉茱萸湯の有用性に関する研究-塩酸ロメリジンとのオープン・クロスオーバー試験. 痛みと漢方 2006 ; 16 : 30-9.

3) 磯濱洋一郎. 五苓散のアクアポリンを介した水分代謝調節メカニズム. 漢方医学 2011 ; 35 : 186-9.

P.85 掲載の参考文献

1) 慢性頭痛の診療ガイドライン作成委員会. 薬物療法以外にどのような治療法があるか. 慢性頭痛の診療ガイドライン 2013, 医学書院, 2013, p45-6.

2) Spierings EL, Ranke AH, et al. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001 ; 41 : 554-8.

3) Holm JE, Lokken C, et al. Migraine and stress : a daily examination of temporal relationships in women migraineurs. Headache 1997 ; 37 : 553-8.

4) Holroyd KA1, Drew JB, et al. Impaired functioning and quality of life in severe migraine : the role of catastrophizing and associated symptoms. Cephalalgia 2007 ; 27 : 1156-65.

5) Holroyd KA, Nash JM, et al. A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches. J Consult Clin Psychol 1991 ; 59 : 387-93.

6) D'Souza PJ1, Lumley MA, et al. Relaxation training and written emotional disclosure for tension or migraine headaches : a randomized, controlled trial. Ann Behav Med 2008 ; 36 : 21-32.

7) Kaushik R, Kaushik RM, et al. Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine. Complement Ther Med 2005 ; 13 : 165-74.

8) Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache : a meta-analytic review of clinical trials. Pain 1990 ; 42 : 1-13.

9) Mullally WJ1, Hall K, et al : Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician 2009 ; 12 : 1005-11.

P.97 掲載の参考文献

1) Silberstein SD. Practice parameter : evidence-based guidelines for migraine headache (an evidence-based review) : report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 ; 55 : 754-62.

2) Kelman L : The triggers or precipitants of the acute migraine attack. Cephalalgia 2007 27 : 394-402.

3) 日本神経学会・日本頭痛学会. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013.

4) Okada K, et al. Analgesic action of acupuncture and moxibustion : a review of unique approaches in Japan. Evid Based Complement Alternat Med 2009 ; 6 : 11-7.

5) Linde K, et al. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009 ; 1 : CD001218.

6) Linde K et al. Acupuncture for tension-type headache. Cochrane Database Syst Rev (1) : CD007587, 2009.

7) Sakai F, et al. Migraine specific cervical tender points during the interictal period of frequent migraine ; clinically detectable and treatable phenomenon of trigemino-cervical sensitization. Cephalalgia 2011 ; 31 : 102.

8) Lance JW, Goadsby PJ. Mechanism and management of headache. 7th ed. Oxford, Butterworth-Heinemann, 2005.

9) Piovesan EJ, et al. Massaging over the greater occipital nerve reduces the intensity of migraine attacks : evidence for inhibitory trigemino-cervical convergence mechanisms. Arq Neuropsiquiatr 2007 ; 65 : 599-604.

10) Serra G, et al. Occipital nerve stimulation for chronic migraine : a randomized trial. Pain Physician 2012 ; 15 : 245-53.

11) Schoenen J et al : Migraine prevention with a supraorbital transcutaneous stimulator : a randomized controlled trial. Neurology 2013 ; 80 : 697-704.

12) Schoenen J, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1 : A randomized, sham-controlled study. Cephalalgia 2013 ; 33 : 816-30.

13) Lipton RB, Pearlman SH. Transcranial magnetic simulation in the treatment of migraine. Neurotherapeutics 2010 ; 7 : 204-12.

14) Diener HC et al : Integrated headache care. Cephalalgia 2011 ; 31 : 1039-47.

P.104 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類委員会 (訳). 国際頭痛分類第3版 (beta版). 医学書院, 東京, 2014.

2) 日本頭痛学会. 慢性頭痛の診療ガイドライン 2013. 東京, 医学書院, 2013

3) Nappi G, Jesen R, Nappi RE, et al. Diaries and calendars for migraine. A review. Cephalalgia 2006 ; 26 : 905-16.

4) 飯ケ谷美峰. 診療支援ツール (スクリーナー, 重症度, 頭痛ダイアリー). 鈴木則宏編, 頭痛診療ハンドブック, 中外医学社, 東京, 2009, p31-46.

5) 飯ケ谷美峰. 頭痛診療支援ツール (スクリーナー, 重症度評価票, 頭痛ダイアリー). 辻省次, 鈴木則宏編, 識る診る治す頭痛のすべて, 中山書店, 東京, 2011, p41-50.

6) 小川果林. 頭痛診療支援ツール-コミュニケーションツール. 頭痛最前線-よりよき頭痛診療をめざして. 間中信也, 喜多村孝幸編, 医学のあゆみ, 医歯薬出版社, 東京, 2012, p1031-7.

7) 坂井文彦. 診療アシストパケージの活用. 厚生労働科学研究費補助金効果的医療技術の確立推進研究事業片頭痛の具体的な医療手順に関する研究, 平成15年度総括・分担研究報告書, 2004, p59-65.

P.112 掲載の参考文献

1) Sakai F, Igarashi H. Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 1997 ; 17 : 15-22.

2) 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013, p61-3.

3) Gaul C, Visscher CM, et al. Team players against headache : multidisciplinary treatment of primary headaches and medication overuse headache. J headache Pain 2011 ; 12 : 511-9.

4) Zeeberg P, Olesen J, et al. Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 2005 ; 1159-67.

III 各頭痛の診断と治療の進め方

P.134 掲載の参考文献

1) Sakai F, Igarashi H. Prevalence of migraine in Japan : a nationwide survey. Cephalalgia 1997 ; 17 : 15-22.

2) Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door-to-door survey of migraine in Japan : the Daisen study. Headache 2004 ; 44 : 8-19.

3) 慢性頭痛の診療ガイドライン作成委員会編集. 慢性頭痛の診療ガイドライン 2013 (日本神経学会・日本頭痛学会監集), 医学書院, 東京, 2013.

4) Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013 ; 33 : 629-808.

5) 日本頭痛学会・国際頭痛分類委員会訳 : 国際頭痛分類第3版 beta版, 医学書院, 東京, 2014.

6) Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944 ; 78 : 359-90.

7) Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990 ; 28 : 791-8.

8) Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001 ; 98 : 4687-92.

9) Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984 ; 16 : 157-68.

10) Siberstein SD, Lipton RB, Solomon S, et al. Classification of daily and near-daily headaches : proposed revisions to the IHS criteria. Headache 1994 ; 34 : 1-7.

11) Lyngberg AC, Rasmussen BK, Jorgensen T, et al. Prognosis of migraine and tension-type headache : A population-based follow-up study. Neurology 2005 ; 65 : 580-5.

12) Yurekli VA, Akhan G, Kutluhan S, et al. The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 2008 ; 9 : 37-41.

13) Silberstein SD, Lipton RB, Dodick DW, et al. Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine : a randomized, double-blind, placebo-controlled trial. Headache 2007 ; 47 : 170-80.

14) Diener HC, Bussone G, Van Oene JC, et al. TOPMATMIG-201 (TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine : a randomized, double-blind, placebo-controlled study. Cephalalgia 2007 ; 27 : 814-23.

15) Couch JR. Amitriptyline versus Placebo Study Group. Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache. 2011 ; 51 : 33-51.

16) 柴田護. 慢性片頭痛の診療. 最新医学 2014 ; 69 : 1137-44.

P.154 掲載の参考文献

1) The international Classification of Headache Disorders, 3rd edition (beta version). International Headache Society 2013.

2) Stovner LJ, Hagen K, et al. The global burden of headache : A documentation of headache prevalence and disability world wide. Cephalalgia 2007 ; 27 : 193-210.

3) 下村登規夫 : 頭痛の疫学. 日内会誌 1993 ; 82 : 8-13.

4) Bendtsen L, Fumal A, et al. Tension-type headache : mechanisms. Handb Clin Neurol 2010 ; 97 : 359-66.

5) Kitagawa Y, Okayasu H, et al. Effect of eperisone hydrochloride on tension-type headache : Assessment with a pressure-displacement transducer. Cephalalgia 1991 ; Suppl 11 : 335-6.

6) Ristic D, Spangenberg P. Acetylsalicylic acid inhibits α,β-meATP-induced facilitation of neck muscle nociception in mice-implications for acute treatment of tension-type headache. Eur J Pharmacol 2011 ; 673 : 13-9.

7) Tomoe B, Andersen LL, et al. Reduced neck-shoulder muscle strength and aroboc power together with increased pericranial tenderness are associated with tension-type headache in girls : Acase-control study. Cephalagia 2013 ; 34 : 540-47.

8) Arendt-Nielsen L, Sluka KA. Experimental muscle pain impairs descending inhibitaion. Pain 2008 ; 140 : 465-71.

9) Buchgreitz L, Egsgaard LL, et al. Abnormal pain processing in chronic tension-type headache : a high-density EEG brain mapping study. Brain 2008 ; 131 : 323-8.

10) Rossi P, Vollono C, et al. The contribution of clinical neurophysiology to the comprehension of the tension-type headache mechanisms. Clin Neurophysiol 2011 ; 122 : 1075-85.

11) Olsen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Parmacol Ther 2008 ; 120 : 157-71.

12) Yildirim G, Savin R, et al. Randomised controlled blink reflex in patients with migraine and tension type headache. J Pak Med Assoc 2011 ; 61 : 978-82.

13) Bezov D, Ashina S, et al. Pain perception studies in tension-type headache. Headache 2011 ; 51 : 262-71.

14) Blaauw BA, Dyb G, et al. Anxiety, depression and behavioral problems among adplescents with recurrent headache : the Young-HUNT study. J Headache Pain 2014 ; 15 : 1129-33.

15) 山口智. 鍼治療がヒトの瞳孔反応に及ぼす影響. 自律神経 2003 ; 40 : 157-61.

16) Chris DV, Stuart C, et al. Peripheral interleukin-1β levels are elevated in chronic tension-type headache patients. Pain Res Manag 2013 ; 18 : 301-6.

17) Dodick, D, Freitag F. Evidence-based understanding of medication-overuse headache : clinical implications. Headache 2006 ; 46 : 202-11.

18) Fumal A, Schoenen J. Tension-type headache : current research and clinical management. Lancet Neurol 2008 ; 7 : 70-83.

19) Packman E, Packman B, et al. Lumiracozib is effective in the treatment of episodic tension-type headache. Headache 2005 ; 45 : 1163-70.

20) Pompili M, Di Cosimo D, Innamorati M, et al. Psychiatric comorbidity in patients with chronic daily headache and migraine : A selective overview including personality traits and suicide risk. J Headache Pain 2009 ; 10 : 283-90.

21) Nestoriuc Y, Rief W. Meta-analysis of bio-feedback for tension-type headache : efficacy, specificity, and treatment moderators. J Consult Clin Psychol 2008 ; 76 : 379-96.

22) van Ettekoven H, Lucas C. Efficacy of physiotherapy including a craniocervical training programme for tension-type headache ; a randomized clinical trial. Cephalalgia 2006 ; 26 : 983-91.

23) Linde K, Allais G, et al. Acupuncture for tension-type headache. Cochrane Database Syst Rev 2009 ; 21 : CD007587.

24) Silberstein SD, Gobel H, et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache : a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 2006 ; 26 : 790-800.

25) Naumann M, So Y, Argoff CE, et al. Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008 ; 70 : 1707-14.

P.170 掲載の参考文献

1) 日本頭痛学会・国際頭痛分類委員会. 国際頭痛分類第3版 beta版日本語版, 医学書院, 東京, 2014.

2) 日本頭痛学会編. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013.

3) Leone M, Lucini V, D'Amico D, et al. Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 1995 ; 15 : 224-9.

4) May A, Bahra A, Buchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998 ; 352 : 275-8.

5) May A, Ashburner J, Buchel C, et al. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med 1999 ; 5 : 836-8.

6) Wang SJ, Lirng JF, Fuh JL, Chen JJ. Reduction in hypothalamic 1H-MRS metabolite ratios in patients with cluster headache. J Neurol Neurosurg Psychiatry 2006 ; 77 : 622-5.

7) Lodi R, Pierangeli G, Tonon C, et al. Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy. Neurology 2006 ; 66 : 1264-6.

8) Rainero I, Gallone S, Valfre W, et al. A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 2004 ; 63 : 1286-8.

9) Holland P, Goadsby PJ. The hypothalamic orexinergic system : pain and primary headaches. Headache 2007 ; 47 : 951-62.

10) Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 1997 ; 120 : 193-209.

11) Steinberg A, Wiklund NP, Brundin L, Remahl AI. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache. Cephalalgia 2010 ; 30 : 696-702.

12) Moskowitz MA. Cluster headache : evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus. Headache 1988 ; 28 : 584-6.

13) May A. Cluster headache : pathogenesis, diagnosis, and management. Lancet 2005 ; 366 : 843-55.

14) Drummond PD. Mechanisms of Autonomic Disturbance in the Face During and Between Attacks of Cluster Headache. Cephalalgia 2006 ; 26 : 633-41.

15) Ito Y, Yamamoto T, Ninomiya M, et al. Secondary SUNCT syndrome caused by viral meningitis. J Neurol 2009 ; 256 : 667-8.

16) Sjostrand C, Waldenlind E,Ekbom K. A follow-up study of 60 patients after an assumed first period of cluster headache. Cephalalgia 2000 ; 20 : 653-7.

17) Manzoni GC, et al. Cluster headache-course over ten years in 189 patients. Cephalalgia 1991 ; 11 : 169-74.

P.189 掲載の参考文献

1) Headache Classification Committee, Olesen J, Bousser MG, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006 ; 26 : 742-6.

2) Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013 ; 33 : 629-808.

3) 日本頭痛学会・国際頭痛分類委員会 : 国際頭痛分類第3版 beta版, 医学書院, 東京, 2014.

4) 日本神経学会・日本頭痛学会監修. 慢性頭痛の診療ガイドライン作成委員会編集. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013.

5) Westergaad ML, Holme Hsndrn E, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates : A systemic review. Cephalalgia 2014 ; 34 : 409-25.

6) Imai N, Kitamura E, et al. Clinical features of probable medication-overuse headache : a retrospective study in Japan. Cephalalgia 2007 ; 27 : 1020-3.

7) Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 2010 ; 9 : 391-401.

8) Headache classification subcommittee of the international headache society : The Inteinational Classification of Headache Disorders ; 2nd edition. Cephalalgia. 2004 ; 24 (suppl 1) : 1-160.

9) Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II) -revision of criteria for 8.2 Medicationoveruse headache. Cephalalgia 2005 ; 25 : 460-5.

10) 渡邉由佳, 山本真也, ほか. 薬物乱用頭痛の病名に対する意識調査第42回頭痛学会総会一般演題口演発表.

11) Evers S, Jensen R. European Federation of Neurological Societies. Treatment of medication overuse headacheguideline of the EFNS headache panel. Eur J Neurol 2011 ; 18 : 1115-21.

12) 高瀬靖, 岸上仁, ほか. 鎮痛薬の高度な乱用による頭痛の長期予後. 臨床神経学. 2005 ; 45 : 629-33.

13) Creac'h C, Frappe P, Cancade M, et al. In-patient versus out-patient withdrawal programmes for medication overuse headache : a 2-year randomized trial. Cephalalgia 2011 ; 31 (11) : 1189-98.

14) Boe MG, Mygland A, et al. Prednisolone does not reduce withdrawal headache : a randomized, double-blind study. Neurology 2007 ; 69 : 26-31.

15) Hagen K, Stovner LJ. A randomized controlled trial on medication-overuse headache : outcome after 1 and 4 years. Acta Neurol Scand Suppl 2011 ; (191) : 38-43.

16) Silberstein SD, Lipton RB, et al. Efficacy and safety of topiramate for the treatment of chronic migraine : a randomized, double-blind, placebo-controlled trial. Headache 2007 ; 47 : 170-80.

17) Diener HC, Bussone G, et al. Topiramate reduces headache days in chronic migraine : a randomized, double-blind, placebo-controlled study. Cephalalgia 2007 ; 27 : 814-23.

18) Descombes S, Brefel-Courbon C, et al. Amitriptyline treatment in chronic drug-induced headache : a double-blind comparative pilot study. Headache 2001 ; 41 : 178-82.

19) Linton-Dahlof P, Linde M, et al. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication : a retrospective study. Cephalalgia 2000 ; 20 : 658-62.

20) Sances G, Ghiotto N, et al. Risk factors in medication-overuse headache : a 1-year follow-up study (care II protocol). Cephalalgia. 2010 ; 30 : 329-36.

21) 渡邉由佳, 鈴木紫布, ほか. 性格気質調査を用いた片頭痛慢性化における心理的要因の評価第39回日本頭痛学会一般演題口演発表.

P.213 掲載の参考文献

1) 藤田光江. 小児・思春期の頭痛. 識る診る治す頭痛のすべて (辻省次, 鈴木則宏編), 中山書店, 東京, 2011, p224-49.

2) 安藤直樹, 岡西徹, ほか. 当院頭痛外来を受診した小児頭痛の分類と特徴. 日本頭痛学会誌 2010 ; 37 : 6-8.

3) 藤田光江, 磯部規子, ほか. 小児慢性反復性頭痛の研究第4編 : 一般小児科から他科へ依頼する頭痛. 日児誌 2001 ; 105 : 576-83.

4) Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd edition. Cephalalgia 24 (suppl 1) ; 2004 : 1-160.

5) Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8 (Suppl 7) : 1-96.

6) 藤田光江. 頭痛. 小児内科 (増刊号) 2012 : 44 : 18-9.

7) ウイリス動脈輪閉鎖症における病態・治療に関する研究班. もやもや病 (ウイリス動脈輪閉鎖症) 診断・治療ガイドライン. 脳卒中の外科 2009 : 37 : 321-37.

8) 松島善治, 青柳傑, ほか. 小児モヤモヤ病における頭痛と間接的血管吻合術EDAS前後の変化について. 小児の脳神経 2000 ; 25 : 442-7.

9) 日本神経学会・日本頭痛学会 : 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013, p2-343.

10) Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 3nd edition (beta version). Cephalalgia 2013 ; 33 : 629-808.

11) 日本頭痛学会・国際頭痛分類委員会. 国際頭痛分類第3版 beta版, 医学書院, 東京, 2014, p3-205.

12) 藤田光江, 牧たか子, ほか. 小児片頭痛における家族集積性の検討. 日本頭痛学会誌 2010 ; 36 : 239-43.

13) Lewis DW : Pediatric migraine. Neurol Clin 2009 ; 27 : 481-501.

14) Seshia SS, Wang SJ, et al. Chronic daily headache in children and adolescents : a multi-faceted syndrome. Can J Neurol Sci 2010 ; 37 : 769-78.

15) Silberstein SD, Lipton RB, et al. Classification of daily and near-daily headaches : field trial of revised IHS criteria. Neurology 1996 ; 47 : 871-5.

16) 藤田光江. 小児・思春期の頭痛. 日本小児科医会会報 2013 ; 46 : 124-7.

17) 清水利彦. 片頭痛における慢性化のメカニズム. 日本頭痛学会誌 2011 ; 38 : 56-8.

18) 藤田光江. 小児頭痛の慢性化のリスク要因について. 日本頭痛学会誌 2011 ; 38 : 75-7.

19) 田中英高, 石谷暢男, ほか. 小児起立性調節障害. 診断・診療ガイドライン, 日本小児心身医学会編. 小児心身医学会ガイドライン集, 南江堂, 東京, 2009, p2-54.

20) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition : DSM-IV. Washington DC, American Psychiatric Association, 1994, p1-686.

21) Fujita M, Fujiwara J, et al. Pediatric chronic daily headache associated with school phobia. Pediatr Int 2009 ; 51 : 621-5.

22) 日本頭痛学会. 頭痛ダイアリー (http://www.jhsnet.org/dr_medical_diary.html)

23) 藤田光江, 藤原順子. 小児一次性頭痛におけるグラフ式頭痛ダイアリーの有用性. 脳と発達 2011 ; 43 : 443-7.

24) 村上佳津美, 有村秀人, ほか. 小児科医のための不登校診療ガイドライン. 小児心身医学会ガイドライン集, 日本小児心身医学会編, 南江堂, 東京, 2009, p69.

25) 日本頭痛協会 (http://www.zutsuu-kyoukai.jp/)

P.228 掲載の参考文献

1) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33 : 629-808, 2013.

2) Headache classification subcommittee of the international headache society : The Inteinational Classification of Headache Disorders ; 2nd edition. Cephalalgia 24 (suppl 1) : 1-160, 2004.

3) 日本循環器学会ほか2011年度合同研究班報告. 失神の診断と治療に関するガイドライン (2012年改訂版) www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf

4) 日本神経学会・日本頭痛学会監修, 慢性頭痛の診療ガイドライン作成委員会編集. 慢性頭痛の診療ガイドライン 2013, 医学書院, 東京, 2013.

書評

書評を投稿する

最近チェックした商品履歴

Loading...